Mark Cuban calls for end to generic drug application fees to boost domestic manufacturing
Mark Cuban, the billionaire businessman and founder of the online discount pharmacy Cost Plus Drugs, is urging the Trump...
Tag: TEVA
Teva outlines path to $2.5B AUSTEDO revenue in 2027 as innovative portfolio grows 33%
Earnings Call Insights: Teva Pharmaceutical Industries Limited (TEVA) Q3 2025 CEO Richard Francis highlighted the company's...
Earnings Snapshot: Teva Pharmaceutical Industries tops Q3 estimates; updates FY outlook above forecast
Teva Vs. Viatris: Who Will Dominate In President Trump's America? Teva Pharmaceutical: Turnaround Driven By Huge...
Teva gains after Q3 beat and guidance hike
Shares of Teva Pharmaceutical (TEVA) jumped ~11% in the premarket on Wednesday after the generic drugmaker posted...
Teva Pharmaceutical Non-GAAP EPS of $0.78 beats by $0.11, revenue of $4.48B beats by $150M
Teva Pharmaceutical press release (TEVA): Q3 Non-GAAP EPS of $0.78 beats by $0.11. Revenue of $4.48B (+4.2% Y/Y) beats by...
Teva Pharmaceutical Q3 2025 Earnings Preview
Teva Pharmaceutical (TEVA) is scheduled to announce Q3 earnings results on Wednesday, November 5th, before market open. The...
Teva long-acting antipsychotic Uzedy gains indication for bipolar disorder
The U.S. FDA has expanded the indication for Teva Pharmaceutical Industries' (NYSE:TEVA) long-acting atypical antipsychotic...
FDA introduces program to expedite review of domestic generic drugs
The U.S. Food and Drug Administration has introduced a new pilot program aimed at accelerating the review process for...
Bausch, Teva face lawsuit for delay in generic version of Xifaxan
Bausch Health (NYSE:BHC) and Teva (NYSE:TEVA) are facing a lawsuit accusing them of conspiring to delay the release of a...
Teva gets FDA fast track status for multiple system atrophy drug
Teva Pharmaceuticals (NYSE:TEVA) said that the U.S. FDA has granted fast track designation to its experimental therapy...